Position in BIIB
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$9,577,723
+$1,387,089 QoQ
Shares Held
44,329
-0.8% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
1.83%
of 13F equity value
Holder Rank
#177
of 1,031 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CONTRAVISORY INVESTMENT MANAGEMENT, INC. holds $32,212,697 across 8 Drug Manufacturers - General names. BIIB ranks #2 (29.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
76,643 | $9,848,625 | |
| 2 | BIIB |
Biogen Inc.
This page
|
44,329 | $9,577,723 | |
| 3 | PFE |
Pfizer Inc
|
299,290 | $7,206,903 | |
| 4 | LLY |
ELI LILLY & Co
|
2,955 | $3,544,315 | |
| 5 | JNJ |
Johnson & Johnson
|
4,341 | $1,102,483 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,737 | $724,812 | |
| 7 | ABBV |
AbbVie Inc.
|
777 | $195,524 | |
| 8 | AMGN |
Amgen Inc
|
34 | $12,312 |
All Filings in BIIB
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,577,723 | 44,329 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $8,190,634 | 44,677 | Shares | Sole | 2026-04-20 | |
| No filing history on record for this holder in this stock. | ||||||